Ulf Bredberg

2.5k citations

33 papers · 1.9k indexed · h-index 21

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism

Papers in

Pharmacology 13
- Pharmacogenetics and Drug Metabolism 10
- Drug-Induced Hepatotoxicity and Protection 5
Oncology 17
- Drug Transport and Resistance Mechanisms 15

Co-authors: Margareta Hammarlund‐Udenaes Markus Fridén Ulf G. Eriksson Madeleine Antonsson Tommy B. Andersson David Gustafsson Collen Masimirembwa Hong Wan
Journals: Drug Metabolism and Disposition (7 papers)Pharmaceutical Research (3 papers)Biopharmaceutics & Drug Disposition (2 papers)Molecular Pharmaceutics (2 papers)Drug Discovery Today (2 papers)
Partner nations: Sweden Denmark Singapore

In The Last Decade

Ulf Bredberg

33 papers receiving 1.8k citations

Peers

Countries citing papers authored by Ulf Bredberg

Since Specialization

Citations

This map shows the geographic impact of Ulf Bredberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Bredberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Bredberg more than expected).

Fields of papers citing papers by Ulf Bredberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Bredberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Bredberg. The network helps show where Ulf Bredberg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ulf Bredberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulf Bredberg Line = papers co-authored together Ulf Bredberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Model-based drug discovery: implementation and impact Drug Discovery Today ·Sandra A. G. Visser, J. L. Brito, Rhys D.O. Jones, Virna Schuck, Ann‐Charlotte Egnell, Sheila Annie Peters, So In Kim, James Yates, Rasmus Jansson‐Löfmark, Laura Elice de Souza Ferreira Miranda, Marie Cooke, Simon T. Barry, Andrew Hughes, Ulf Bredberg	2013	46
2	Hepatic Disposition of Ximelagatran and Its Metabolites in Pig; Prediction of the Impact of Membrane Transporters Through a Simple Disposition Model Pharmaceutical Research ·Erik Sjögren, Ulf Bredberg, A. S. Gendy, Björn Arvidsson, Jonas Bergquist, Tommy B. Andersson, Hans Lennernäs	2010	3
3	Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods Drug Metabolism and Disposition ·Markus Fridén, Fredrik Bergström, Hong Wan, E. V. Nechayev, Gustav Ahlin, Margareta Hammarlund‐Udenaes, Ulf Bredberg	2010	129
4	Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous System Drug Metabolism and Disposition ·Markus Fridén, Parisini Antonella, Brian Middleton, Madeleine Antonsson, Ulf Bredberg, Margareta Hammarlund‐Udenaes	2009	87
5	Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations Drug Discovery Today ·Johan Gabrielsson, Hugues Dolgos, Per‐Göran Gillberg, Ulf Bredberg, Д В Ворончихин, Göran Duker	2009	74
6	In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular Fluids Drug Metabolism and Disposition ·Markus Fridén, 蒋继国, Madeleine Antonsson, Ulf Bredberg, Margareta Hammarlund‐Udenaes	2007	146
7	Prediction of Drug Tissue to Plasma Concentration Ratios Using a Measured Volume of Distribution in Combination With Lipophilicity Journal of Pharmaceutical Sciences ·Rasmus Jansson‐Löfmark, Ulf Bredberg, Michael Ashton	2007	43
8	A new oral anticoagulant: the 50-year challenge Nature Reviews Drug Discovery ·David Gustafsson, 曹丽娟, Thomas Antonsson, Ingemar Nilsson, Jan-Erik Nyström, Ulf G. Eriksson, Ulf Bredberg, Ann‐Catrine Teger‐Nilsson	2004	99
9	Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans Drug Metabolism and Disposition ·Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann, Mihaela Tănase, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Ma. Teresa Iranzo Muñío, Gunnar Fager, David Gustafsson	2003	125
10	Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects European Journal of Clinical Pharmacology ·Ulf G. Eriksson, Ulf Bredberg, Ma. Teresa Iranzo Muñío, Prof. Jaydeep Pipaliya, Lars Frison, Martin Ahnoff, David Gustafsson	2003	116
11	The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects Thrombosis Research ·David Gustafsson, Jan-Erik Nyström, Stefan Carlsson, Ulf Bredberg, Ulf G. Eriksson, Erika Gyzander, Margareta Elg, Thomas Antonsson, Kurt‐Jürgen Hoffmann, Anna‐Lena Ungell, Henrik Toft Sørensen, Васютин Олег Иванович, Anna Abrahamsson, 曹丽娟	2001	236
12	Stereoselective Metabolism by Human Liver CYP Enzymes of A Substituted Benzimidazole Drug Metabolism and Disposition ·Angela Äbelö, Tommy B. Andersson, Ulf Bredberg, Inger Skånberg, Lars Weidolf	2000	16
13	Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug Biopharmaceutics & Drug Disposition ·Ulf G. Eriksson, Lars Renberg, Ulf Bredberg, Ann‐Catrine Teger‐Nilsson, C G Regårdh	1998	19
14	The protective action of chlormethiazole against ischaemia‐induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity British Journal of Pharmacology ·A.J. Cross, J. A. Jones, Trinidad Jiménez Piqueras, K.‐G. Jostell, Ulf Bredberg, Geovana Isabel Lopez Mamani	1995	42
15	A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans Clinical Pharmacology & Therapeutics ·Ulf Bredberg, Mats O. Karlsson, Teng Hong-lin	1992	8
16	Mathematical description of the concentration of Oxytetracycline and penicillin‐G in tissue cages in calves as related to the serum concentration Journal of Veterinary Pharmacology and Therapeutics ·Björn Bengtsson, Ulf Bredberg, J. Luthman	1992	7
17	In vivo evaluation of the semi‐simultaneous method for bioavailability estimation using controlled intravenous infusion as an ‘extravascular’ route of administration Biopharmaceutics & Drug Disposition ·Ulf Bredberg, Mats O. Karlsson	1991	2
18	Pharmacokinetics of Methylergometrine in the Rat: Evidence for Enterohepatic Recirculation by a Linked-Rat Model Pharmaceutical Research ·Ulf Bredberg, Lennart Paalzow	1990	6
19	Bioavailability estimation by semisimultaneous drug administration: A Monte Carlo simulation study Journal of Pharmacokinetics and Biopharmaceutics ·Mats O. Karlsson, Ulf Bredberg	1990	12
20	Estimation of Bioavailability on a Single Occasion After Semisimultaneous Drug Administration Pharmaceutical Research ·D. Gerdeaux, Ulf Bredberg	1989	12

About Ulf Bredberg

Ulf Bredberg is a scholar working on Pharmacology, Oncology, Statistics and Probability, Analytical Chemistry and Computational Theory and Mathematics, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Pharmacogenetics and Drug Metabolism (10 papers), Computational Drug Discovery Methods (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Statistical Methods in Clinical Trials (5 papers), Analytical Methods in Pharmaceuticals (5 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Internal Medicine (266 citations), Pharmacology (352 citations), Oncology (621 citations), Computational Theory and Mathematics (262 citations) and Cardiology and Cardiovascular Medicine (356 citations). Ulf Bredberg has collaborated with scholars based in Sweden, Denmark and Singapore. Frequent co-authors include Margareta Hammarlund‐Udenaes, Markus Fridén, Ulf G. Eriksson, Madeleine Antonsson, Tommy B. Andersson, David Gustafsson, Collen Masimirembwa, Hong Wan, Brian Middleton and Martin Ahnoff. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, Biopharmaceutics & Drug Disposition, Molecular Pharmaceutics and Drug Discovery Today.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact